F.D.A. Sees Flaws in Theranos’ Handling of Device and Complaints
The Food and Drug Administration inspected the blood testing company recently, which led it to stop using its finger-prick device for all but one procedure.








from NYT > Technology http://ift.tt/1kNjl6l
via IFTTT
from NYT > Technology http://ift.tt/1kNjl6l
via IFTTT
Commentaires
Enregistrer un commentaire